ASTRAZENECA PLC 13D and 13G filings for ADC Therapeutics SA:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-12 10:13 am Unchanged |
2023-12-31 | 13G | ADC Therapeutics SA ADCT |
ASTRAZENECA PLC | 4,011,215 4.880% |
0 (Unchanged) |
Filing |
| 2021-02-10 4:01 pm Purchase |
2020-05-11 | 13G | ADC Therapeutics SA ADCT |
ASTRAZENECA PLC | 4,011,215 5.230% |
4,011,215 (New Position) |
Filing |